Julia Shifman

11PUBLICATIONS
20CO-AUTHORS
Gene and molecular therapyProteomics and metabolomicsIndustrial molecular engineering of nucleic acids and proteinsMedical molecular engineering of nucleic acids and proteinsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Oct 29, 2025
Engineered N-TIMP2 Variant Specifically Targeting MMP-9 Exhibits Potent Anti-Glioblastoma Activity.

Mark Feldman, Naama Rotenberg, Julia M Shifman

|May 09, 2025
ProBASS-a language model with sequence and structural features for predicting the effect of mutations on binding affinity.

Sagara N S Gurusinghe, Yibing Wu, William DeGrado

|Oct 26, 2024
Proximal Co-Translation Facilitates Detection of Weak Protein-Protein Interactions.

Alina Kordonsky, Matan Gabay, Aurelia Rosinoff

|Sep 28, 2024
Improving Circulation Half-Life of Therapeutic Candidate N-TIMP2 by Unfolded Peptide Extension.

Jason Shirian, Alexandra Hockla, Justyna J Gleba

|Jul 09, 2024
Improving Circulation Half-Life of Therapeutic Candidate N-TIMP2 by Unfolded Peptide Extension.

Jason Shirian, Alexandra Hockla, Justyna J Gleba

|Jul 09, 2024
ProBASS - a language model with sequence and structural features for predicting the effect of mutations on binding affinity.

Sagara N S Gurusinghe, Yibing Wu, William DeGrado

Pageof 2